A Study of Evacetrapib in Participants With Abnormal Cholesterol

NCT02168803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Evacetrapib

Sponsor

Eli Lilly and Company